8-KAcquisitions & DispositionsExhibits & Filings

CVS HEALTH Corp 8-K Report, Acquisition Completed (Jun 2, 2006)

Filed June 2, 2006For Securities:CVS

Summary

CVS Corporation (CVS) filed an 8-K on June 2, 2006, to report the completion of its acquisition of approximately 700 standalone drugstores and a distribution center from Albertson’s, Inc. This significant transaction, referred to as the "Standalone Drug Business," was purchased for $3.93 billion in an asset purchase agreement. The acquired stores are primarily located in Southern California and other Midwestern and Western states, marking a substantial expansion for CVS. The company financed this acquisition through a combination of its Bridge Facility and commercial paper issuance, with plans to secure longer-term financing in the third quarter of 2006. Furthermore, CVS intends to monetize a significant portion of the owned real estate associated with these newly acquired stores through sale-leaseback transactions, expecting to raise up to $1.0 billion. This strategy aims to improve capital efficiency and potentially reduce immediate debt burden.

Key Highlights

  • 1Completion of acquisition of approximately 700 standalone drugstores and one distribution center from Albertson's, Inc.
  • 2The acquired assets are referred to as the "Standalone Drug Business" and are primarily located in Southern California, Illinois, Arizona, Indiana, Nevada, Missouri, Wisconsin, and Kansas.
  • 3The purchase price for the acquisition was $3.93 billion, structured as an asset purchase.
  • 4Acquisition was financed through a combination of CVS's Bridge Facility and commercial paper issuance.
  • 5CVS plans to secure longer-term financing in Q3 2006 to repay a portion of the commercial paper.
  • 6Company expects to monetize owned real estate of acquired drugstores through sale-leaseback transactions, potentially raising up to $1.0 billion.
  • 7Financial statements and pro forma information for the acquired business will be filed as an amendment within 75 days.

Frequently Asked Questions

The main purpose of this 8-K filing was to officially report the completion of CVS Corporation's acquisition of approximately 700 standalone drugstores and a distribution center from Albertson’s, Inc. on June 2, 2006.

CVS financed the $3.93 billion acquisition using proceeds from its Bridge Facility and the issuance of commercial paper. They intend to replace some of this commercial paper debt with longer-term financing later in 2006.

The sale-leaseback transaction is significant because CVS plans to sell and lease back the real estate associated with the newly acquired drugstores. This is expected to generate up to $1.0 billion and helps manage the capital invested in the acquisition, potentially improving cash flow and reducing the overall financial outlay.

Investors can expect to see the financial statements of the acquired business and pro forma financial information in an amendment to this 8-K filing, which CVS expects to file no later than 75 days following June 2, 2006.